SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science submits newspaper advertisements

22 Oct 2019 Evaluate

With reference to letter dated October 19, 2019 relating to intimation of Board Meeting scheduled to be held on Friday, October 25, 2019 to consider and approve the Unaudited Financial Results (Standalone and Consolidated basis) for the quarter and half year ended September 30, 2019, Strides Pharma Science has informed that, in compliance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, the Company submitted copies of newspaper advertisements published in Business Standard (English Edition) and Lokmat (Marathi Edition), both dated October 19, 2019. 

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×